4 Largecap China Plus One Stocks to Watch for Future Multibagger Potential: Divi's Labs, Pidilite, Polycab and Laurus Labs

China plus one stocks to watch for multibagger potential start with a simple filter: size, a clean financial record and earnings that keep growing. Divi's Labs, Pidilite, Polycab and Laurus Labs meet that test, with market caps from Rs 1.04 lakh crore to Rs 2.34 lakh crore and Divi's Labs offering the largest market cap at Rs 2,34,429 crore. Each of these companies has a return on equity of at least 10 per cent and net profit growth in FY26 and in the latest quarter, and net profit rose in FY26 and in the latest quarter.

This list covers companies with a return on equity of at least 10 per cent and net profit growth in FY26 and in the latest quarter, rising profit in FY26 and the latest quarter, market capitalisation above Rs 1,00,000 crore, and complete, verifiable financials, ranked by market capitalisation. Each company has a market cap above Rs 1 lakh crore. Investors screening China plus one stocks usually begin with size and balance sheet strength, and this list follows the same logic. All figures are as of 23 October 2026 and are drawn from NSE and BSE data and company filings.

Click Here – Get Free Investment Predictions

What Are China Plus One Stocks and Why Do They Attract Multibagger Interest?

China plus one stocks are shares of large companies that stand to gain as global buyers add India as a second manufacturing source alongside China, from chemicals and electronics to components and speciality materials. The four here cover pharmaceutical ingredients, adhesives, cables and specialty pharma.

Global companies keep widening their supplier base beyond China, and Indian manufacturers with scale and growing profit are natural candidates for new orders. For China plus one stocks, both FY26 and the latest quarter showed growth. For China plus one stocks, checking each result against the latest quarter matters more than any single ratio. The next sections explain what stands out in each of China plus one stocks, using FY26 and latest quarter data. Prices move daily, so recheck the figures for China plus one stocks before you decide.

China Plus One Stocks at a Glance: Price, Market Cap, PE and ROE

Prices are closing prices as of 23 October 2026. Polycab has the lowest PE of the group at 41.32, while Pidilite posts the highest return on equity at 22.61%.

Stock	CMP (Rs)	Market Cap (Rs Cr)	PE	Industry PE	ROE	Debt to Equity	52-Week Range (Rs)
Divi's Laboratories	8,950	2,34,429	80.15	36.42	15.32%	0.00	5,647.50 to 9,740.00
Pidilite Industries	1,487.70	1,53,879	57.51	36.15	22.61%	0.04	1,259.00 to 1,707.50
Polycab India	7,440	1,20,055	41.32	49.96	22.25%	0.02	6,663.00 to 10,126.00
Laurus Labs	1,970	1,03,921	95.31	36.42	16.77%	0.48	864.70 to 2,085.90

Divi's Labs: Debt-to-Equity of 0.00

Divi's Laboratories makes active pharmaceutical ingredients and intermediates and runs a large custom synthesis business for global drug companies. It reported FY26 revenue of Rs 11,067 crore, up 13.95% year on year, and net profit of Rs 2,568 crore, up 17.21%. Revenue has compounded at 5.09% a year since FY22. Operating margin was 36.70% in FY26. The debt-to-equity ratio is 0.00, which keeps interest costs low.

In the June 2026 quarter, revenue rose 24.32% to Rs 3,144 crore and net profit grew 65.50% to Rs 902 crore. The share price has gained 71.04% over five years and 38.43% over the past year. Foreign investors raised their holding from 19.39% in September 2025 to 20.38% in September 2026. The stock trades at a PE of 80.15 against an industry PE of 36.42, with a return on equity of 15.32%.

Pidilite: Return on Equity of 22.61%

Pidilite Industries makes Fevicol, Dr. Fixit and other adhesives and construction chemicals. It reported FY26 revenue of Rs 14,867.01 crore, up 11.05% year on year, and net profit of Rs 2,470.72 crore, up 17.87%. Net profit has compounded at 19.62% a year since FY22, while revenue has grown 10.54% a year. Operating margin was 25.81% in FY26. The debt-to-equity ratio is 0.04, which keeps interest costs low.

The stock trades at a PE of 57.51 against an industry PE of 36.15, with a return on equity of 22.61%. In the June 2026 quarter, revenue rose 20.96% to Rs 4,643.55 crore and net profit grew 30.29% to Rs 883.51 crore. Domestic institutions raised their holding from 9.15% in June 2025 to 9.88% in June 2026.

Polycab: 33.79% Profit CAGR Since FY22

Polycab India is a leading maker of wires and cables in India, with a growing fast-moving electrical goods business. It reported FY26 revenue of Rs 29,120.04 crore, up 28.76% year on year, and net profit of Rs 2,708.43 crore, up 32.41%. Net profit has compounded at 33.79% a year since FY22, while revenue has grown 24.06% a year. Operating margin was 14.69% in FY26. The debt-to-equity ratio is 0.02, which keeps interest costs low.

In the June 2026 quarter, revenue rose 38.90% to Rs 8,314.65 crore and net profit grew 32.84% to Rs 796.65 crore. The share price has gained 230.55% over five years. Foreign investors raised their holding from 11.44% in June 2025 to 19.00% in June 2026. The stock trades at a PE of 41.32 against an industry PE of 49.96, below the sector average, with a return on equity of 22.25%.

Laurus Labs: Revenue Up 22.01% in FY26

Laurus Labs makes active pharmaceutical ingredients and formulations and offers contract development and manufacturing services. It reported FY26 revenue of Rs 6,867.85 crore, up 22.01% year on year, and net profit of Rs 889.85 crore, up 151.08%. Revenue has compounded at 8.53% a year since FY22. Operating margin was 26.90% in FY26. The debt-to-equity ratio is 0.48.

The stock trades at a PE of 95.31 against an industry PE of 36.42, with a return on equity of 16.77%. In the June 2026 quarter, revenue rose 28.83% to Rs 2,035.49 crore and net profit grew 124.73% to Rs 361.99 crore. The share price has gained 221.40% over five years and 137.53% over the past year. Domestic institutions raised their holding from 11.94% in June 2025 to 13.74% in June 2026.

China Plus One Stocks: Financial Comparison on Growth and Margins

The table compares scale and growth across these China plus one stocks. Latest quarter means the most recent reported quarter for each company, and only metrics that are positive for every company are shown.

Stock	Revenue (Rs Cr)	Net Profit (Rs Cr)	Revenue Growth (YoY)	4-Year Revenue CAGR	Latest Quarter Revenue Growth	Operating Margin (Latest Quarter)
Divi's Labs	11,067	2,568	13.95%	5.09%	24.32%	42.82%
Pidilite	14,867.01	2,470.72	11.05%	10.54%	20.96%	28.62%
Polycab	29,120.04	2,708.43	28.76%	24.06%	38.90%	15.12%
Laurus Labs	6,867.85	889.85	22.01%	8.53%	28.83%	31.95%

Check the Univest Screener for live data on these China plus one stocks

Institutional Holding in Divi's Labs, Pidilite, Polycab and Laurus Labs

Institutional holding shows who is backing these China plus one stocks alongside the promoter. The table uses the latest reported quarter for each. Laurus Labs has the deepest institutional backing, with FII and DII together holding 41.74% as of June 2026. Domestic institutions increased their holding over the past year in Pidilite (from 9.15% to 9.88%) and Laurus Labs (from 11.94% to 13.74%).

Stock	Promoter	FII	DII	Public	Quarter
Divi's Labs	51.88%	20.38%	19.17%	8.58%	September 2026
Pidilite	69.24%	11.69%	9.88%	9.18%	June 2026
Polycab	61.46%	19.00%	7.62%	11.92%	June 2026
Laurus Labs	27.47%	28.00%	13.74%	30.78%	June 2026

Risks to Weigh in China Plus One Stocks

Being careful with China plus one stocks means looking at what can slow the story as well as what can speed it up. Four points matter most:

• Past growth may not repeat.
• Share prices can move sharply in either direction.
• Valuation: Laurus Labs trades at a PE of 95.31 against an industry PE of 36.42, so earnings need to keep growing to support the price.
• Concentration: Holding all 4 names puts the allocation in one sector, so size each position to match your risk appetite.

How to Choose Between China Plus One Stocks

Picking from China plus one stocks comes down to four checks, applied in order.

1. Check balance sheet strength first, and prefer a debt-to-equity ratio below 1 for non-financial companies.
2. Compare each PE with the industry PE (36.15 to 49.96) and ask whether the growth rate justifies any gap.
3. Track net profit growth, the operating margin and the return on equity in every quarterly result.
4. Stagger entries across quarters and review institutional holding every reporting season.

Download the Univest iOS App or Univest Android App to track Divi's Labs, Pidilite, Polycab and Laurus Labs live prices.

Conclusion

Among China plus one stocks, Divi's Labs stands out for the largest market cap at Rs 2,34,429 crore, Pidilite for the highest return on equity at 22.61%, Polycab for the fastest profit growth, 33.79% a year since FY22 and Laurus Labs for the strongest latest-quarter profit growth at 124.73%. Which one suits a portfolio depends on how much valuation risk it can carry, so staggering entries and reviewing each quarterly result is a sound habit. Investors comparing China plus one stocks should rank them on growth, financial strength and the price paid, and anyone who wants personalised guidance can consult a SEBI-registered advisor before acting.

Frequently Asked Questions on China Plus One Stocks to Watch

Which are the best China plus one stocks to watch for multibagger potential?

Ans. Divi's Labs, Pidilite, Polycab and Laurus Labs are the 4 names this list highlights, with market caps of Rs 2,34,429 crore, Rs 1,53,879 crore, Rs 1,20,055 crore and Rs 1,03,921 crore respectively. Divi's Labs is notable for the largest market cap at Rs 2,34,429 crore. Pidilite stands out for the highest return on equity at 22.61%. Polycab offers the fastest profit growth, 33.79% a year since FY22. Laurus Labs brings the strongest latest-quarter profit growth at 124.73%. These are watchlist names for China plus one stocks, not recommendations, so match each one to your own risk profile and time horizon.

Is Pidilite a good stock for long-term investors?

Ans. Pidilite has a return on equity of 22.61%, a PE of 57.51 against an industry PE of 36.15 and a market cap of Rs 1,53,879 crore. Net profit has compounded at 19.62% a year since FY22, and FY26 revenue rose 11.05% while June 2026 quarter net profit grew 30.29%. Long-term returns in China plus one stocks depend on earnings growth and the price paid at entry, so staggering purchases and consulting a SEBI-registered advisor is sensible.

Can Polycab become a multibagger from here?

Ans. Polycab has already gained 230.55% in five years, so another multi-fold move would need sustained earnings growth. A multibagger outcome in China plus one stocks requires earnings to keep growing faster than the market for several years. Net profit has compounded at 33.79% a year since FY22, and FY26 revenue rose 28.76%. At a PE of 41.32 against an industry PE of 49.96, valuation should be checked against that growth before investing.

What is the market cap of Divi's Labs, Pidilite, Polycab and Laurus Labs?

Ans. As of 23 October 2026, Divi's Labs has a market cap of Rs 2,34,429 crore, Pidilite has a market cap of Rs 1,53,879 crore, Polycab has a market cap of Rs 1,20,055 crore and Laurus Labs has a market cap of Rs 1,03,921 crore. All of them qualify as largecaps. Market cap changes daily with the share price, so check the latest figure on the Univest Screener or on NSE before taking a decision on China plus one stocks.

What are the risks of investing in China plus one stocks?

Ans. The main risks are market swings, slower growth than expected and valuations that already reflect good news. Companies with strong balance sheets and steady earnings handle these better. Laurus Labs trades at a PE of 95.31 against an industry PE of 36.42, so earnings growth needs to hold up.

Why is Laurus Labs trading at a PE of 95.31?

Ans. Laurus Labs' PE of 95.31 compares with an industry PE of 36.42. The market is paying a premium for a return on equity of 16.77%, latest-quarter profit growth of 124.73% and FY26 revenue growth of 22.01%, which also means the stock is more sensitive if growth slows. Investors in China plus one stocks who are comfortable with higher valuation risk may prefer to stagger purchases instead of investing in one go.

How much do institutions hold in Divi's Labs, Pidilite, Polycab and Laurus Labs?

Ans. As of the latest reported quarter, FII and DII together hold 39.55% of Divi's Labs (20.38% and 19.17%), 21.57% of Pidilite (11.69% and 9.88%), 26.62% of Polycab (19.00% and 7.62%) and 41.74% of Laurus Labs (28.00% and 13.74%). Rising institutional holding is a useful signal in China plus one stocks, though it should be read with earnings trends rather than on its own.